- Home
- NQP vs ZVRA Comparison
NQP vs ZVRA Comparison
Compare NQP & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NQP
- ZVRA
- Stock Information
- Founded
- NQP 1990
- ZVRA 2006
- Country
- NQP United States
- ZVRA United States
- Employees
- NQP N/A
- ZVRA N/A
- Industry
- NQP Trusts Except Educational Religious and Charitable
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- NQP Finance
- ZVRA Health Care
- Exchange
- NQP Nasdaq
- ZVRA Nasdaq
- Market Cap
- NQP 423.5M
- ZVRA 433.5M
- IPO Year
- NQP N/A
- ZVRA 2015
- Fundamental
- Price
- NQP $11.12
- ZVRA $7.85
- Analyst Decision
- NQP
- ZVRA Strong Buy
- Analyst Count
- NQP 0
- ZVRA 8
- Target Price
- NQP N/A
- ZVRA $22.29
- AVG Volume (30 Days)
- NQP 58.4K
- ZVRA 513.4K
- Earning Date
- NQP 01-01-0001
- ZVRA 03-11-2025
- Dividend Yield
- NQP 3.21%
- ZVRA N/A
- EPS Growth
- NQP N/A
- ZVRA N/A
- EPS
- NQP N/A
- ZVRA N/A
- Revenue
- NQP N/A
- ZVRA $23,612,000.00
- Revenue This Year
- NQP N/A
- ZVRA $281.10
- Revenue Next Year
- NQP N/A
- ZVRA $97.98
- P/E Ratio
- NQP N/A
- ZVRA N/A
- Revenue Growth
- NQP N/A
- ZVRA N/A
- 52 Week Low
- NQP $9.65
- ZVRA $4.20
- 52 Week High
- NQP $11.89
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- NQP 30.56
- ZVRA 47.41
- Support Level
- NQP $11.11
- ZVRA $7.78
- Resistance Level
- NQP $11.45
- ZVRA $8.33
- Average True Range (ATR)
- NQP 0.08
- ZVRA 0.40
- MACD
- NQP -0.03
- ZVRA -0.01
- Stochastic Oscillator
- NQP 2.17
- ZVRA 45.30
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.